Comparison of two interferon gamma release assays in the diagnosis of <it>Mycobacterium tuberculosis </it>infection and disease in The Gambia
<p>Abstract</p> <p>Background</p> <p>IFN-γ Release Assays (IGRAs) have been licensed for the diagnosis of latent <it>Mycobacterium tuberculosis </it>infection (LTBI). Their performance may depend on assay format and may vary across populations and settings....
Main Authors: | Donkor Simon, Jeffries David, Hammond Abdulrahman, Lugos Moses D, Adetifa Ifedayo MO, Adegbola Richard A, Hill Philip C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/7/122 |
Similar Items
-
Performance of Interferon-γ Release Assays in Patients with Mycobacterium kansasii Infection
by: Gao CH, et al.
Published: (2022-12-01) -
Interferon-gamma release assay for screening of tuberculosis infection in children
by: Huiwen Zheng, et al.
Published: (2023-12-01) -
Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion
by: Jason D. Simmons, et al.
Published: (2022-06-01) -
Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population
by: Ying Yang, et al.
Published: (2022-02-01) -
Interferon Gamma Release Assays in active Tuberculosis: new medical insights
by: Sandro Pierdomenico, et al.
Published: (2011-09-01)